These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 9543465)

  • 1. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease.
    Crismon ML
    Pharmacotherapy; 1998; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapeutic approaches to Alzheimer's disease.
    Schneider LS
    J Clin Psychiatry; 1996; 57 Suppl 14():30-6. PubMed ID: 9024334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.
    Jann MW; Shirley KL; Small GW
    Clin Pharmacokinet; 2002; 41(10):719-39. PubMed ID: 12162759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic approaches to cognitive impairment.
    Schneider LS
    J Clin Psychiatry; 1998; 59 Suppl 11():8-13. PubMed ID: 9731544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medications for the treatment of Alzheimer's disease.
    Lampley-Dallas VT
    J Okla State Med Assoc; 2001 Aug; 94(8):347-9. PubMed ID: 11515383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alzheimer's disease. Foreword].
    Derquesné C
    Rev Prat; 1998 Nov; 48(17):1871-2. PubMed ID: 9882238
    [No Abstract]   [Full Text] [Related]  

  • 7. Alzheimer's disease: new pharmacological perspectives.
    Palacios JM
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():67-8. PubMed ID: 8899698
    [No Abstract]   [Full Text] [Related]  

  • 8. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of action of Alzheimer medications].
    Alhainen K
    Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
    [No Abstract]   [Full Text] [Related]  

  • 10. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
    Doody RS
    J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic agents for Alzheimer's disease].
    Honma A
    Nihon Naika Gakkai Zasshi; 1998 Jan; 87(1):169-74. PubMed ID: 9513562
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.
    Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
    Eur J Pharmacol; 2000 Feb; 389(2-3):173-9. PubMed ID: 10688981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats.
    Goh CW; Aw CC; Lee JH; Chen CP; Browne ER
    Drug Metab Dispos; 2011 Mar; 39(3):402-11. PubMed ID: 21148081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
    Darreh-Shori T; Hosseini SM; Nordberg A
    J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for managing Alzheimer's disease: Part II. Treatment.
    Cummings JL; Frank JC; Cherry D; Kohatsu ND; Kemp B; Hewett L; Mittman B
    Am Fam Physician; 2002 Jun; 65(12):2525-34. PubMed ID: 12086242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating Alzheimer's disease with cholinergic drugs, Part 2.
    Terpstra T; Terpstra T
    Nurse Pract; 1999 Jan; 24(1):117-9. PubMed ID: 9950002
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
    Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs for Alzheimer's disease in Japan.
    Takeda M; Tanaka T; Okochi M
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):399-404. PubMed ID: 21851448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.